- Phare
- Validé par KD/KO
Anticorps Monoclonal anti-NHE1
NHE1 Monoclonal Antibody for WB, ELISA
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain, rat
Applications
WB, IHC, ELISA
Conjugaison
Non conjugué
CloneNo.
3D9F3
N° de cat : 67363-1-Ig
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules A549, cellules HEK-293, cellules HSC-T6, cellules Jurkat, cellules LNCaP, cellules NCI-H1299, cellules PC-12 |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:5000-1:50000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 1 publications below |
WB | See 6 publications below |
IHC | See 2 publications below |
Informations sur le produit
67363-1-Ig cible NHE1 dans les applications de WB, IHC, ELISA et montre une réactivité avec des échantillons Humain, rat
Réactivité | Humain, rat |
Réactivité citée | rat, Humain |
Hôte / Isotype | Mouse / IgG1 |
Clonalité | Monoclonal |
Type | Anticorps |
Immunogène | NHE1 Protéine recombinante Ag14329 |
Nom complet | solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
Masse moléculaire calculée | 815 aa, 91 kDa |
Poids moléculaire observé | 110 kDa |
Numéro d’acquisition GenBank | BC012121 |
Symbole du gène | NHE1 |
Identification du gène (NCBI) | 6548 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par protéine G |
Tampon de stockage | PBS with 0.02% sodium azide and 50% glycerol |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
NHE1, also named as SLC9A1, is involved in pH regulation that can eliminate acids generated by active metabolism and counter adverse environmental conditions. NHE1 plays an important role in signal transduction. It has been shown that NHE1 participates in the development and progression of human breast cancer, gastric cancer and others. NHE1 has some isoforms with 91 kDa , 110 kDa (phosphoglycoprotein) and 210 kDa (dimeric protein). (PMID:28098891, 27751915, 8300588)
Protocole
Product Specific Protocols | |
---|---|
WB protocol for NHE1 antibody 67363-1-Ig | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Acta Pharmacol Sin Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling.
| ||
Reproduction An abnormal LPA/LPAR1-NHE1 axis leads to the autophagy deficiency of trophoblast cells in recurrent spontaneous abortion | ||
Cell Rep Carbonic anhydrase 2 facilitates sorafenib resistance by counteracting MCT4-mediated intracellular pH dysregulation in HCC | ||
Cell Rep Mitochondrial transplantation rescues Ca2+ homeostasis imbalance and myocardial hypertrophy in SLC25A3-related hypertrophic cardiomyopathy | ||
bioRxiv Cystinosin is involved in Na+/H+ Exchanger 3 trafficking in the proximal tubular cells: new insights in the renal Fanconi syndrome in cystinosis | ||
Adv Sci (Weinh) A Human Engineered Heart Tissue-Derived Lipotoxic Diabetic Cardiomyopathy Model Revealed Early Benefits of Empagliflozin |